02/27/2026 | Press release | Distributed by Public on 02/27/2026 08:20
|
Delaware
(State or other jurisdiction of incorporation or organization)
|
84-4618156
(I.R.S. Employer Identification No.)
|
||||
|
1600 District Avenue, Burlington, MA
(Address of Principal Executive Offices)
|
01803
(Zip Code)
|
||||
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. | |||||
|
Large accelerated filer
|
Accelerated filer
|
||||||||||
|
Non-accelerated filer
|
Smaller Reporting Company
|
||||||||||
|
Emerging Growth Company
|
|||||||||||
|
Exhibit Number |
Description | Filed Herewith |
Incorporated by Reference herein from
Form or Schedule
|
Filing Date | SEC File/Reg. Number | |||||||||||||||||||||||||||
| 4.1 |
Form 8-K
(Exhibit 3.1)
|
6/13/2024 | 001-39292 | |||||||||||||||||||||||||||||
| 4.2 |
Form 8-K
(Exhibit 3.2)
|
2/16/2021 | 001-39292 | |||||||||||||||||||||||||||||
| 4.3 |
Form 8-K
(Exhibit 4.1)
|
2/16/2021 | 001-39292 | |||||||||||||||||||||||||||||
| 5.1 |
Opinion of Foley Hoag LLP.
|
X | ||||||||||||||||||||||||||||||
| 23.1 |
Consent of Deloitte & Touche LLP, independent registered public accounting firm of Butterfly Network, Inc.
|
X | ||||||||||||||||||||||||||||||
| 23.2 |
Consent of Foley Hoag LLP (included in Exhibit 5.1).
|
X | ||||||||||||||||||||||||||||||
| 24.1 |
Power of Attorney (included on the signature page hereof).
|
X | ||||||||||||||||||||||||||||||
| 99.1+ |
Form 10-K
(Exhibit 10.19.1)
|
3/29/2021 | 001-39292 | |||||||||||||||||||||||||||||
| 99.2+ |
Form 10-Q
(Exhibit 10.1)
|
8/1/2024 | 001-39292 | |||||||||||||||||||||||||||||
| 107 |
Filing Fee Table
|
X | ||||||||||||||||||||||||||||||
| Signature | Title |
Date
|
||||||
|
/s/ Joseph DeVivo
Joseph DeVivo
|
President, Chief Executive Officer, and Chairman of the Board (Principal Executive Officer) |
February 27, 2026
|
||||||
|
/s/ John Doherty
John Doherty
|
Executive Vice President, Chief Financial Officer
(Principal Financial Officer) |
February 27, 2026
|
||||||
|
/s/ Megan Carlson
Megan Carlson
|
Chief Accounting Officer (Principal Accounting Officer) |
February 27, 2026
|
||||||
|
/s/ Dawn Carfora
Dawn Carfora
|
Director |
February 27, 2026
|
||||||
|
/s/ Elazer Edelman, M.D., Ph.D.
Elazer Edelman, M.D., Ph.D.
|
Director |
February 27, 2026
|
||||||
|
/s/ S. Louise Phanstiel
S. Louise Phanstiel
|
Director
|
February 27, 2026
|
||||||
|
/s/ Larry Robbins
Larry Robbins
|
Director
|
February 27, 2026
|
||||||
|
/s/ Jonathan M. Rothberg, Ph.D.
Jonathan M. Rothberg, Ph.D.
|
Director |
February 27, 2026
|
||||||
|
/s/ Erica Schwartz, M.D., J.D., M.P.H
Erica Schwartz, M.D., J.D., M.P.H.
|
Director |
February 27, 2026
|
||||||